Akari Therapeutics(AKTX) - 2019 Q4 - Annual Report
AKTXAkari Therapeutics(AKTX)2020-03-31 09:46

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F Title of each class Trading Symbol(s) Name of each exchange on which registered American Depositary Shares, each representing 100 Ordinary Shares, par value £0.01 per share AKTX The Nasdaq Capital Market (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended De ...